UniProt ID | CD276_HUMAN | |
---|---|---|
UniProt AC | Q5ZPR3 | |
Protein Name | CD276 antigen | |
Gene Name | CD276 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 534 | |
Subcellular Localization |
Membrane Single-pass type I membrane protein . |
|
Protein Description | May participate in the regulation of T-cell-mediated immune response. May play a protective role in tumor cells by inhibiting natural-killer mediated cell lysis as well as a role of marker for detection of neuroblastoma cells. May be involved in the development of acute and chronic transplant rejection and in the regulation of lymphocytic activity at mucosal surfaces. Could also play a key role in providing the placenta and fetus with a suitable immunological environment throughout pregnancy. Both isoform 1 and isoform 2 appear to be redundant in their ability to modulate CD4 T-cell responses. Isoform 2 is shown to enhance the induction of cytotoxic T-cells and selectively stimulates interferon gamma production in the presence of T-cell receptor signaling.. | |
Protein Sequence | MLRRRGSPGMGVHVGAALGALWFCLTGALEVQVPEDPVVALVGTDATLCCSFSPEPGFSLAQLNLIWQLTDTKQLVHSFAEGQDQGSAYANRTALFPDLLAQGNASLRLQRVRVADEGSFTCFVSIRDFGSAAVSLQVAAPYSKPSMTLEPNKDLRPGDTVTITCSSYQGYPEAEVFWQDGQGVPLTGNVTTSQMANEQGLFDVHSILRVVLGANGTYSCLVRNPVLQQDAHSSVTITPQRSPTGAVEVQVPEDPVVALVGTDATLRCSFSPEPGFSLAQLNLIWQLTDTKQLVHSFTEGRDQGSAYANRTALFPDLLAQGNASLRLQRVRVADEGSFTCFVSIRDFGSAAVSLQVAAPYSKPSMTLEPNKDLRPGDTVTITCSSYRGYPEAEVFWQDGQGVPLTGNVTTSQMANEQGLFDVHSVLRVVLGANGTYSCLVRNPVLQQDAHGSVTITGQPMTFPPEALWVTVGLSVCLIALLVALAFVCWRKIKQSCEEENAGAEDQDGEGEGSKTALQPLKHSDSKEDDGQEIA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
104 | N-linked_Glycosylation | PDLLAQGNASLRLQR HHHHHCCCCEEEEEE | 17.80 | 19159218 | |
106 | Phosphorylation | LLAQGNASLRLQRVR HHHCCCCEEEEEEEE | 20.30 | 27251275 | |
144 (in isoform 1) | Ubiquitination | - | 34.96 | 21906983 | |
144 (in isoform 2) | Ubiquitination | - | 34.96 | 21906983 | |
144 (in isoform 3) | Ubiquitination | - | 34.96 | 21906983 | |
144 (in isoform 4) | Ubiquitination | - | 34.96 | 21906983 | |
144 | Ubiquitination | QVAAPYSKPSMTLEP EEECCCCCCCCEECC | 34.96 | - | |
189 | N-linked_Glycosylation | QGVPLTGNVTTSQMA CCCCCCCCEEHHHHC | 23.79 | 19159218 | |
215 | N-linked_Glycosylation | LRVVLGANGTYSCLV HHHHHCCCCEEEEEE | 41.35 | UniProtKB CARBOHYD | |
236 | O-linked_Glycosylation | QDAHSSVTITPQRSP CCCCCCCEECCCCCC | 22.53 | OGP | |
244 | Phosphorylation | ITPQRSPTGAVEVQV ECCCCCCCCCEEEEC | 38.73 | 25022875 | |
262 | Phosphorylation | PVVALVGTDATLRCS CEEEEEECCCEEEEE | 18.25 | 18452278 | |
265 | Phosphorylation | ALVGTDATLRCSFSP EEEECCCEEEEECCC | 19.97 | 18452278 | |
303 (in isoform 2) | Ubiquitination | - | 46.51 | - | |
308 (in isoform 2) | Ubiquitination | - | 9.95 | 21906983 | |
322 | N-linked_Glycosylation | PDLLAQGNASLRLQR HHHHHCCCCEEEEEE | 17.80 | 19159218 | |
324 | Phosphorylation | LLAQGNASLRLQRVR HHHCCCCEEEEEEEE | 20.30 | 27251275 | |
362 | Ubiquitination | QVAAPYSKPSMTLEP EEECCCCCCCCEECC | 34.96 | - | |
383 | S-palmitoylation | GDTVTITCSSYRGYP CCEEEEEECCCCCCC | 1.94 | 29575903 | |
407 | N-linked_Glycosylation | QGVPLTGNVTTSQMA CCCCCCCCEEHHHHC | 23.79 | 19159218 | |
433 | N-linked_Glycosylation | LRVVLGANGTYSCLV HHHHHCCCCEEEEEE | 41.35 | UniProtKB CARBOHYD | |
495 | Phosphorylation | CWRKIKQSCEEENAG HHHHHHHHHHHHCCC | 20.63 | 25002506 | |
496 | S-palmitoylation | WRKIKQSCEEENAGA HHHHHHHHHHHCCCC | 7.65 | 29575903 | |
513 | Phosphorylation | QDGEGEGSKTALQPL CCCCCCCCCEECEEC | 23.64 | 26657352 | |
515 | Phosphorylation | GEGEGSKTALQPLKH CCCCCCCEECEECCC | 34.01 | 30266825 | |
521 | Ubiquitination | KTALQPLKHSDSKED CEECEECCCCCCCCC | 47.98 | - | |
523 | Phosphorylation | ALQPLKHSDSKEDDG ECEECCCCCCCCCCC | 41.83 | 30266825 | |
525 | Phosphorylation | QPLKHSDSKEDDGQE EECCCCCCCCCCCCC | 40.74 | 29255136 | |
526 (in isoform 1) | Ubiquitination | - | 70.88 | 21906983 | |
526 | Ubiquitination | PLKHSDSKEDDGQEI ECCCCCCCCCCCCCC | 70.88 | 2190698 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CD276_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CD276_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CD276_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of CD276_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-322 AND ASN-407, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-525, AND MASSSPECTROMETRY. |